Captopril CAS 62571-86-2 Hypertension Treatment EINECS NO 263-607-1

Product Description:

Product Name: Captopril CAS NO: 62571-86-2

Synonyms:

(2S)-1-[(2S)-3-Mercapto-2-methylpropionyl]-2-pyrrolidinecarboxylic acid;

1-[(S)-3-Mercapto-2-methylpropionyl]-L-proline;

Captopril,N-[(S)-3-Mercapto-2-methylpropionyl]-L-proline;

Chemical & Physical Properties:

Appearance: White to off-white crystalline power

Assay :≥99.00%

Density: 1.272 g/cm3

Boiling Point: 427℃ at 760 mmHg

Melting Point: 103-108℃

Flash Point: 212.1℃

Refractive Index: -127.5 ° (C=1.7, EtOH)

Water Solubility: Soluble

Stability: Stable. Incompatible with strong oxidizing agents.

Storage Condition: Store in a cool, dry place. Store in a tightly closed container.

Safety Information:

RTECS: UY0550000

Safety Statements: S26-S37/39

HS Code: 2933990090

WGK Germany: 2

Risk Statements: R36/37/38

Hazard Code: Xi

Signal Word: Warning

Hazard Declaration: H317; H361

Caution Statement: P280

Symbols: GHS07, GHS08

Captopril (rINN) is an angiotensin-converting enzyme (ACE) inhibitor used for the treatment of hypertension and some types of congestive heart failure. Captopril was the first ACE inhibitor developed and was considered a breakthrough both because of its novel mechanism of action and also because of the revolutionary development process. Captopril was discovered and developed at E. R. Squibb & Sons Pharmaceuticals based on concepts pioneered by Nobel Laureate John Vane and is now marketed by Bristol-Myers Squibb under the trade name Capoten.

If you are interested in our products or have any questions, please feel free to contact us!

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.